Year-end Sale % OFF 
Abstract
Editorial: Special Issue. Current Treatment of Localized Renal Cancer
Highlights
Both in retrospective large series and prospective trials approximately 15% of small solid renal masses are benign lesions
Renal cell cancer (RCC) constitutes 3% of all solid neoplasms seen in adults and there has been an increase throughout the world
Radical nephrectomy has been the standard treatment for localized disease
Summary
Both in retrospective large series and prospective trials approximately 15% of small solid renal masses are benign lesions. Renal cell cancer (RCC) constitutes 3% of all solid neoplasms seen in adults and there has been an increase throughout the world. This increased incidence is mainly due to incidental detection by imaging for non-urological causes. Despite earlier diagnosis of smaller tumors, the mortality due to RCC is on the rise.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
